Corporate Banner
Satellite Banner
Informatics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Omixon Announces Free Genome Browser

Published: Thursday, January 10, 2013
Last Updated: Wednesday, January 09, 2013
Bookmark and Share
Omixon Target 1.2 includes a free Genome Browser

Omixon, a genomics software company, has announced the release of Omixon Target 1.2 which includes a free Genome Browser. With the Genome Browser users can visualize next generation sequencing and mutation data. The Browser is especially designed for targeted genomic regions.

”Users can view, navigate and analyze genomic variants, display the level of details needed and zoom in to examine the underlying short read data, to verify the variant call,” says Omixon CEO Attila Berces.

"NGS is rapidly being adopted by clinical and research laboratories worldwide. Easy to use analytical methods and software like Omixon are critical for the success of this ground breaking new technology.” said Lajos Pusztai, M.D, PhD. Chief of Breast Medical Oncology Co-Director of the Yale Cancer Center Genetics and Genomics Program Yale School of Medicine.

New features in the Omixon Target HLA typing module include the ability to manually assign alleles, in addition to the application’s existing ablility to do so automatically. New algorithms for enhanced performance on the Ion Torrent and Roche 454 platforms are included with the release.

According to Omixon CTO, Tim Hague, ”this release is a continuation of our commitment to enhance the ability to analyze clinically and diagnostically relevant NGS data.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Omixon, G3 and Genomics England Collaborate
Omixon Collaborates with G3 and Genomics England to Validate HLA Genotyping from WGS Data.
Thursday, September 25, 2014
Scientific News
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
Connectome Map More Than Doubles Human Cortex’s Known Regions
Researchers at NIH have developed software that automatically detects the “fingerprint” of each of these areas in an individual’s brain scans.
Virus Inspired Cell Cargo Ships
Virus-inspired container design may lead to cell cargo ships following construction of ten large, two-component, icosahedral protein complexes.
Three-Drug Combinations Counter Antibiotic Resistance
Research shows that combinations of three different antibiotics can treat resistant bacteria, even if they are ineffective independently.
Supercomputing and Drug Discovery
New biotech company uses supercomputer simulations to speed up drug discovery and biotech molecule development.
Identifying Cancer Drug Targets Using 3D-Modelling
Researchers are now able to model genetic mutations manipulation of proteins that can potentially drive cancer.
Human Evolution Driven by Viruses
Study finds surprising percentage of protein adaptions in humans have been driven by viruses.
Earliest Sign of Alzheimer's Development Discovered
Researchers have identified the first physiological signs of late-onset Alzheimer's disease, underlining the importance of computational power in neurology.
Computational Method Offers Significant Boost in Finding New Cancer Targets
MIT and ARIAD Pharmaceuticals team have identified evidence of significant cancer mutations.
Drug Response Predicted by Cancer Cell Lines
Large-scale study could increase success rate of developing personalised cancer treatments.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!